Comparison of in-office magnetic resonance imaging versus conventional radiography in detecting changes in erosions after one year of infliximab therapy in patients with rheumatoid arthritis
- 20 August 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 17 (4) , 273-278
Abstract
The objective of this study was to compare standard hand radiographs with in-office 0.2 T magnetic resonance imaging (MRI) in monitoring response to therapy in patients with rheumatoid arthritis (RA) who were receiving infliximab, to evaluate the frequency and location of erosions, and to determine if there were differences in outcome based on disease duration at baseline. Patients who satisfied the American College of Rheumatology criteria for RA and were receiving infliximab therapy were evaluated with a baseline and 1-year follow-up MRI. Magnetic resonance images were interpreted by two blinded, board-certified radiologists. Bone erosions were identified as well-defined defects extending through the cortical margin. The mean age of the 48 patients was 58.5 years. The median infliximab dosage was 4 mg/kg. Baseline data showed that 41 patients had abnormal MRIs. The mean time between the baseline and follow-up MRI examinations was 10.5 months. Follow-up MRI revealed regression in 11 patients. Thirty-one patients had both MRIs and radiographs. Magnetic resonance imaging was approximately twice as sensitive as radiography in detecting erosions at baseline. In-office MRI was useful in monitoring disease response after the initiation of infliximab treatment. Magnetic resonance imaging is potentially a very valuable diagnostic tool and prognostic indicator for use in patients with RA.Keywords
This publication has 22 references indexed in Scilit:
- Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve‐month randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2005
- Magnetic resonance imaging of peripheral joints in rheumatic diseasesBest Practice & Research Clinical Rheumatology, 2004
- Imaging of Bone Erosion in Rheumatoid ArthritisSeminars in Musculoskeletal Radiology, 2004
- Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateArthritis & Rheumatism, 2004
- The use of TNF-α blocking agents in rheumatoid arthritis: an overviewExpert Opinion on Pharmacotherapy, 2004
- Infliximab in active early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2004
- Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- Radiographic data from recent randomized controlled trials in rheumatoid arthritis: What have we learned?Arthritis & Rheumatism, 2003
- MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF RHEUMATOID ARTHRITIS—A COMPARISON WITH PLAIN FILM RADIOGRAPHSRheumatology, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988